Editorial
Published on 11 Feb 2026
Editorial: Challenges and opportunities in tumor metabolomics
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1796372
Type at least 3 characters
2,130 articles
articles
Original Research
Accepted on 10 Feb 2026
Identification of core genes and transcription factors related to metabolic reprogramming in atherosclerosis: A multi-omics analysis and experimental validation approach
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
Original Research
Accepted on 09 Feb 2026
Identifying pyroptosis-related lncRNAs to predict prognosis and immune regulation in hepatocellular carcinoma
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
Original Research
Accepted on 09 Feb 2026
Integrated bioinformatics and Mendelian randomization reveal a six-gene diagnostic signature and key role of CYP26B1 in sarcopenia
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
Original Research
Published on 09 Feb 2026
Integrated network analysis and experimental validation identify CCNA2, CD44, and STAT1 as clinically relevant hub genes in oral squamous cell carcinoma
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1748821
- 352 views
Mini Review
Published on 09 Feb 2026
Histone methyltransferase SMYD1: playing a crucial role in disease progression
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1769660
- 241 views
Original Research
Published on 09 Feb 2026
Exploring the gut microbiota-microbial metabolites-targets regulatory network in metabolic dysfunction-associated steatotic liver disease
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1764479
- 230 views
Original Research
Published on 09 Feb 2026
Cuproptosis-related gene signatures define immune subtypes and predict prognosis in gastric cancer
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1746613
- 304 views
Original Research
Accepted on 06 Feb 2026
HSF1 Modulates Lipid Metabolism and Ferroptosis in Sarcopenia: A Novel Diagnostic Biomarker and Therapeutic Target
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
- 238 views
Review
Accepted on 06 Feb 2026
Novel Drugs Targeting Genetic Variants: Current Applications and Future Prospects in Heart Failure Treatment
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
Original Research
Accepted on 06 Feb 2026
Construction of a Robust Sepsis Prognostic Classifier Based on E3 Ubiquitin Ligase-Related Genes
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
Review
Accepted on 05 Feb 2026
Cell-Free Mitochondrial DNA (cf-mtDNA) in Human Body Fluids: Molecular Characteristics, Release Mechanisms, and Clinical Translation—An Updated Review
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
Original Research
Accepted on 04 Feb 2026
Bamboo shoots-derived nanovesicles (BSNs) induce apoptosis in non-small-cell lung cancer A549 cells through the p53 signaling pathway
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
- 244 views
Original Research
Accepted on 04 Feb 2026
Transcriptomic profiling of chlorogenic acid and taurine treatment in human skin cells provides insights into cellular senescence mechanisms
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
- 267 views
Original Research
Accepted on 04 Feb 2026
Optimized RTX Strategy Plus Structured Glucocorticoid Tapering for Primary Membranous Nephropathy: A Multicenter Propensity Score-Matched Cohort Study
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
- 110 views
Correction
Accepted on 03 Feb 2026
Correction: Gasdermin B (GSDMB) in psoriatic patients–a preliminary comprehensive study
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
Editorial
Published on 02 Feb 2026
Editorial: Advancements in immune heterogeneity in inflammatory diseases and cancer: new targets, mechanisms, and strategies
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1794468
- 341 views
Review
Accepted on 30 Jan 2026
Artificial Intelligence-Based miRNA Analysis for Precision Oncology: Diagnostic and Prognostic Insights
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
- 198 views
Original Research
Accepted on 30 Jan 2026
Integrated Transcriptomic, Protein, and MicroRNA Profiling Reveals a Conserved Pyroptosis-Related Molecular Signature Across Breast Cancer Subtypes
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
- 164 views
Original Research
Published on 30 Jan 2026
Arsenic trioxide-induced acute kidney injury: OPA1- and Drp1-mediated mitochondrial dynamics imbalance, PINK1/Parkin-dependent mitophagy, and Chuanhuang Fang III
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1778855
- 565 views
Original Research
Published on 30 Jan 2026
Identification of CXCL12 as a key gene of trophoblast and endometrial stromal cell decidualization in pregnancy via scRNA-seq and experimental validation
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1768015
- 472 views
Original Research
Published on 30 Jan 2026
Longitudinal profiling of serum ADAM17 across clinical stages in multiple myeloma: a dynamic biomarker and its association with T cell alterations
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1768193
- 514 views
Original Research
Published on 29 Jan 2026
Pompe disease: a country-wide molecular screening in a cohort of 15,068 study participants
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2025.1745925
- 1,059 views
Review
Published on 29 Jan 2026
Non-coding RNA transcripts and their exosomal counterparts in the pathogenesis, diagnosis, and treatment of skin cancers, with a focus on melanoma
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2026.1669297
- 626 views